Score Breakdown
Below average.
Core Scientific sits at the intersection of power scarcity and AI demand, possessing a massive 1.5GW pipeline that is highly valuable to hyperscalers. The $10B CoreWeave contract provides a long-term revenue floor and validates their technical capability to deliver high-density liquid cooling. However, the investment is currently a balance sheet and dilution story; the massive warrant overhang (~186M shares) and negative equity position significantly dampen the per-share upside. While management's execution on construction has been industry-leading, the recent accounting restatement and material weakness in internal controls introduce governance risk that offsets the fundamental pivot. At current prices, the market has already priced in much of the CoreWeave success, leaving little room for execution delays or Bitcoin price shocks during the transition.
Negative cash flow. Can't value it.
Major red flags in SEC filings.
Shares melting fast.
No data.
Clock is ticking.
Heavy bearish bets.
Decent.
🔍 What's In The SEC Filings
The company faces a precarious balance between a massive 8-billion-dollar colocation backlog and the reality of a material restatement, deep negative equity, and an impending 60-percent share dilution.
Material Restatement of Previously Issued Financial Statements
“property, plant and equipment was overstated as a result of the improper continued capitalization of carrying values of assets committed to demolition”
The company failed to recognize impairment charges for assets slated for destruction during AI facility conversions, necessitating a restatement of the 10-K for 2024 and multiple 2025 10-Qs.
Extreme Dilution Overhang from Post-Emergence Warrants
“Total shares issuable from potentially dilutive securities 186,264 [in thousands]”
With 314M shares outstanding, the 186M in potentially dilutive securities (primarily Tranche 1 warrants and convertible notes) represents an approximate 59% dilution threat to current shareholders.
Persistent Stockholders Deficit and Negative Equity
“Total Stockholders Deficit: (-$962,740) [in thousands]”
Despite emerging from bankruptcy, the company carries an accumulated deficit of over $4.1 billion, leaving it with a massive equity hole where liabilities exceed assets by nearly $1 billion.
Significant Insider 10b5-1 Selling Plans Adopted
“Todd DuChene... Adopted Rule 10b5-1 520,000 [shares]... Matthew Brown... Adopted Rule 10b5-1 200,000 [shares]”
Key executives, including the Chief Legal Officer and COO, adopted selling plans for 780,000 shares total in late 2025, just as the colocation pivot began to materialize.
The intrinsic value must be heavily discounted for the warrant overhang and the $1 billion equity deficit. Investors should price CORZ as a venture-stage AI infrastructure play rather than an established miner, given the total reliance on uncommenced lease contracts.
The colocation segment revenue is dangerously concentrated with a single customer (Customer J at 100%), and the company faces ongoing patent infringement litigation with a trial date set for 2027.
At the current burn rate, this company will need to raise money or die.